NR5A1 and chronic rhinosinusitis with nasal polyps: By providing the first large‐scale demonstration of ELP's clinical efficacy in CRSwNP patients, our research delivers a comprehensive evaluation of its positive effects on postoperative symptom improvement and inflammation modulation.